6 November 2014

AB Vista has announced revenue growth of more than 20 per cent for the financial year ending 15th September 2014.

The results, which strengthen the company’s position at number three in the global feed enzyme market, includes strong sales growth (over 30%) of its Quantum Blue phytase enzyme, which continues to perform well – particularly since its launch in Europe earlier this year.

AB Vista Managing Director Richard Cooper says the financial performance confirms that the company continues to grow faster than the market.

“We’re committed to delivering value for our customers – right across our business – so we’re proud to see the results pointing to the success of that vision. The year on year growth of AB Vista affirms what we do as a team, and in partnership with our customers around the world.”

Mr Cooper says that a key component of the results is the adoption of phytase superdosing – which has led to increased sales of Quantum Blue, notably in the Americas and a growing penetration in Asia and Europe.

“As a result of the additional value it brings, three of the top five global monogastric feed producers are now superdosing Quantum Blue; we expect the EU market to follow other regions in trending towards this approach to capitalise on the formulation cost and animal performance benefits it delivers.”

AB Vista has also invested in bringing new talent and infrastructure to its business – with 40 new hires this year and a new laboratory in Memphis, Tennessee offering increased capacity and capabilities for its feed assay services.  The new PGPI granulation facility in Evansville, Indiana is operating successfully to meet increasing enzyme demand, and the company has also appointed new distributors in several regions, and secured new product registrations in multiple countries.

Mr Cooper says the business is set to continue with its growth strategy in the year ahead, while maintaining its focus on innovative research and high-quality customer care.

“We’re an expanding and dynamic team of people who love what we do – it’s an exciting time to be involved in the feed sector, and at AB Vista, we’re looking forward to the future.”

AB Vista’s announcement comes on the back of results released by parent company Associated British Foods, which recorded an overall group revenue of £12.9 billion and a profit before tax up 18% to £1,020 billion.


Notes to editor:
AB Vista is a leading global supplier of micro-ingredients for the animal feed industry.

For further press information please contact Nic Daley or Mike Keeler on +44 (0)20 8647 4467.



About Us

AB Vista is an animal nutrition technology company offering pioneering products and technical services to the global animal feed industry. Since its establishment in 2004, AB Vista has grown to be a top-three player in feed enzymes and is also one of the largest suppliers of natural betaine to the global animal nutrition industry. The company invests heavily in research and development and has a growing portfolio of products and services spanning the poultry, swine, ruminant and aquaculture sectors. AB Vista is headquartered in the UK, with regional offices located in the USA, Brazil, Singapore, Spain, India, China, Germany and Finland. AB Vista is part of AB Agri, the agricultural division of Associated British Foods, one of Europe’s largest food & retail companies with a market capitalisation of £22 billion.